BRIEF published on 04/28/2026 at 20:40, 21 days 22 hours ago GenSight Biologics annonce son Assemblée Générale Mixte de 2026 Actionnaires Assemblée Générale Documents Préparatoires Thérapie Génique GenSight Biologics
BRIEF published on 04/28/2026 at 20:40, 21 days 22 hours ago GenSight Biologics Schedules Annual General Meeting for May 2026 Annual General Meeting Regulatory Compliance Shareholder Information Investor Relations Gene Therapy
BRIEF published on 04/28/2026 at 20:40, 21 days 22 hours ago GenSight Biologics programme son assemblée générale annuelle pour mai 2026 Conformité Réglementaire Assemblée Générale Annuelle Thérapie Génique Relations Avec Les Investisseurs Informations Destinées Aux Actionnaires
BRIEF published on 04/28/2026 at 20:40, 21 days 22 hours ago GenSight Biologics announces its 2026 Combined General Meeting Shareholders Gene Therapy General Assembly Preparatory Documents GenSight Biologics
PRESS RELEASE published on 04/28/2026 at 20:35, 21 days 22 hours ago Inside Information / Other news releases GenSight Biologics to hold Annual General Meeting on May 19, 2026, in Paris. Shareholders can access preparatory documents online. Meeting details and documents available on company website Annual General Meeting Shareholders Preparatory Documents Meeting Details GenSight Biologics
PRESS RELEASE published on 04/28/2026 at 20:35, 21 days 22 hours ago Informations privilégiées / Autres communiqués GenSight Biologics annonce sa prochaine Assemblée Générale Mixte du 19 mai 2026 avec mise à disposition des documents préparatoires. Informations complètes disponibles sur le site de la Société Documents Préparatoires Assemblée Générale Mixte GenSight Biologics Thérapies Géniques Maladies Neurodégénératives
BRIEF published on 04/07/2026 at 19:04, 1 month 12 days ago GenSight Biologics : Bilan financier et avancées sur l'AAC Trésorerie Levée De Fonds Thérapie Génique GenSight Biologics Accès Compassionnel
BRIEF published on 04/07/2026 at 19:04, 1 month 12 days ago GenSight Biologics fait le point sur sa trésorerie et ses revenus liés à l'accès anticipé. Thérapie Génique GenSight Biologics Revenu Programme D'accès Anticipé Position De Trésorerie
BRIEF published on 04/07/2026 at 19:04, 1 month 12 days ago GenSight Biologics: Financial Update and Progress on AAC Fundraising Treasury Gene Therapy GenSight Biologics Compassionate Access
BRIEF published on 04/07/2026 at 19:04, 1 month 12 days ago GenSight Biologics Reports Cash Status and Early Access Revenues Revenue Cash Position Gene Therapy GenSight Biologics Early Access Program
Published on 05/20/2026 at 15:28, 3 hours 20 minutes ago Sarama Resources Announces Private Equity Placement of A$1.5m
Published on 05/20/2026 at 15:01, 3 hours 47 minutes ago Kidoz Inc. Appoints Tarrnie Williams Jr. as Chief Operating Officer
Published on 05/20/2026 at 15:00, 3 hours 48 minutes ago BlackBerry Achieves FedRAMP Class D (High) Re-Certification as Government Demand for Mission-Critical Communications Grows
Published on 05/20/2026 at 14:00, 4 hours 48 minutes ago Ameriwest to Advance Its Bornite Copper Project by Re-Logging and Re-Assaying Historical Drill
Published on 05/20/2026 at 14:00, 4 hours 48 minutes ago First Canadian Graphite Reports Encouraging Results at Lac Guéret South from Airborne Survey Indicating Significant Expansion Possibilities
Published on 05/20/2026 at 18:30, 18 minutes ago Orell Füssli AG: Annual General Meeting approves all proposals from the Board of Directors
Published on 05/20/2026 at 17:48, 1 hour ago Commerzbank Annual General Meeting approves all agenda items
Published on 05/20/2026 at 17:46, 1 hour 2 minutes ago Commerzbank Annual General Meeting approves all agenda items
Published on 05/20/2026 at 17:45, 1 hour 3 minutes ago REALITES: Prorogation du délai de complétude des informations nécessaires à la conversion de créances en actions nouvelles
Published on 05/20/2026 at 17:40, 1 hour 8 minutes ago Carvolix : Nombre d’actions composant le capital social et nombre total de droits de vote au 30.04.26.
Published on 05/20/2026 at 17:45, 1 hour 3 minutes ago Report on share repurchases from 13 to 19 May 2026
